Evidence map›Paper›PMID 42657062›Full record

ArticleResearch and reports in urology2026

Glandular Density and Glandular Volume of the Peripheral Zone as Novel Pre-Biopsy Biometric Parameters: A Retrospective Pilot Study.

John M Wolpert, Jordan Kassab, Abdul Awal, Werner T W De Riese

Abstract read
In one paragraph

Article in Research and reports in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John M WolpertDepartment of Urology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.ORCID 0009-0004-4187-238X
Jordan KassabDepartment of Urology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.ORCID 0000-0002-2131-4733
Abdul AwalDepartment of Statistics, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Werner T W De RieseDepartment of Urology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.ORCID 0000-0003-1963-2334

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Currently most patients with elevated PSA and suspicious MRI findings either have no cancer or clinically insignificant cancer on fusion biopsies, driving the need for developing risk to better stratify patients prior to biopsies. This retrospective pilot study demonstrates a novel approach of the glandular tissue volume within the peripheral zone (GVPZ) using pre-operative MRI measurements validated against radical prostatectomy specimens, as the majority of prostate cancer originates within the peripheral zone. Patients and Methods: MRI and clinical parameters of 68 patients were analyzed retrospectively and associated with automated imaging processing data of H&E slides obtained from the corresponding radical prostatectomy specimens. Results: The study results revealed a significant non-linear, inverse relationship between GVPZ and total prostate volume (TPV) (exp(b) = 0.963, SE = 0.008, p < 0.0001). GVPZ decreases as TPV rises, consistent with BPH-driven transition zone expansion progressively diluting glandular tissue content in the peripheral zone. Peripheral zone volume (PZV) was a significant positive predictor of GVPZ (exp(b) = 1.052, SE = 0.014, p < 0.0001). Differences in GDPZ and GVPZ were also observed across racial groups, though these findings are preliminary given the small subgroup sizes. Conclusion: Based on the presented data, total prostate volume is significantly and inversely associated with the glandular volume of the peripheral zone where most primary prostate cancer develops. These tissue-based anatomical markers represent candidate variables for incorporation into future risk calculators; prospective validation against biopsy-confirmed outcomes is required before clinical application.

Indexed as

diagnosticsprostate cancerrisk reductionrisk stratification

Identifiers

PMID42657062
PMCPMC13510222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.